EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles

Yi Wen, Qin Fu, Ashley Soliwoda, Sheng Zhang, Mingfeng Zheng, Wenjun Mao, Yuan Wan

Extracellular Vesicle · 2022

DOI: 10.1016/j.vesic.2022.100004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Extracellular Vesicle, 2022. Verfasst von Yi Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Pq Laboratory of BiomeDx/Rx, Department of Biomedical Engineering, Binghamton University, Binghamton, NY 13902, USA. Die Arbeit wurde bisher 96-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extracellular vesicles (EV) as drug delivery nanocarriers are under intense investigation. Although clinical-grade EVs have been produced on a large-scale, low yield and high production costs of natural EVs (nEV) limit the relevant industrial translation. Recent studies show that mechanical extrusion of cells can generate nEV-like cell-derived nanovesicles (CNV) which can also be used as drug nanocarriers. Moreover, in comparison with nEVs, CNVs have similar physicochemical properties. Nevertheless, a comprehensive comparison of cargo between nEVs and CNVs has not been investigated yet. Therefore, the aim of this study is to profile and compare CNVs to nEVs. Our results show that no significant difference was found in size, morphology, and classical markers between nEVs and CNVs derived from MDA-MB-231 cells. Protein sequencing data reveals the similarity of membrane proteins between the two groups was ~71%, while it was ~21% when pertaining to total protein cargo. Notably, a high similarity of membrane proteins was also found between nEVs and CNVs derived from eight additional cancer cell lines. Moreover, analysis of the top 1000 small RNAs with RNA sequencing showed a ~65% similarity between the two groups. Altogether, we infer from the high similarity of membrane proteins and small RNA cargo that CNVs can be a good substitute for nEVs. In brief, our findings support previous studies with a notion that CNVs yield comparable performance with nEVs and could pave the way for clinical implementation of CNV-based therapeutics in the future.

Schlagwörter

Stichwörter der Autor:innen

Cell engineered vesiclesDrug deliveryExtracellular vesiclesMass spectrometryNext-generation sequencing

Autor:innen und Institutionen

  • The Pq Laboratory of BiomeDx/Rx, Department of Biomedical Engineering, Binghamton University, Binghamton, NY 13902, USA.
  • Proteomics & Metabolomics Facility, Cornell Institute of Biotechnology, Cornell University, Ithaca, NY 14853, USA.
  • Department of Cardiothoracic Surgery, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi Jiangsu 214023, China.

Förderung

  • NCI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Wen, Y., Fu, Q., Soliwoda, A., Zhang, S., Zheng, M., Mao, W., & Wan, Y. (2022). Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles. Extracellular Vesicle. https://doi.org/10.1016/j.vesic.2022.100004

Vancouver

Wen Y, Fu Q, Soliwoda A, Zhang S, Zheng M, Mao W, et al. Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles. Extracellular Vesicle. 2022. doi:10.1016/j.vesic.2022.100004

BibTeX
@article{Wen2022,
  author = {Wen, Yi and Fu, Qin and Soliwoda, Ashley and Zhang, Sheng and Zheng, Mingfeng and Mao, Wenjun and Wan, Yuan},
  title = {Cell-derived nanovesicles prepared by membrane extrusion are good substitutes for natural extracellular vesicles},
  journal = {Extracellular Vesicle},
  year = {2022},
  doi = {10.1016/j.vesic.2022.100004}
}
Kostenlos starten →